Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Ammonaps (sodium phenylbutyrate) - Important Safety Information from Swedish Orphan Biovitrum International AB (Sobi), as approved by the HPRA
Notice type:
3rd Party Publications
Date:
19/12/2016
Problem Or Issue:
Important Safety Information communication from Swedish Orphan Biovitrum International AB (Sobi): Ammonaps (sodium phenylbutyrate) tablets and granules should only be used when there is no alternative treatment.
Important Safety Information - Ammonaps (sodium phenylbutyrate)
« Back
Date Printed: 24/04/2024